Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible by Richard E. Gilbert, Kim A. Connelly

Get full text

Policies to Prevent Sudden Cardiac Death in Young Athletes: Challenging, But More Testing Is Not the Answer by Paul Dorian, Jack M. Goodman, Kim A. Connelly

Get full text

Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction by Kim A. Connelly, Yanling Zhang, Jean-François Desjardins, Kerri Thai, Richard E. Gilbert

Get full text

Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling by Patrick B. Meagher, Xavier Alexander Lee, Joseph Lee, Aylin Visram, Mark K. Friedberg, Kim A. Connelly

Get full text

Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD by David M Kepecs, Darren A Yuen, Yanling Zhang, Kerri Thai, Kim A Connelly, Richard E Gilbert

Get full text

Repeated Treatment with Bone Marrow Cell Secretory Products Maintains Long-Term Renoprotection in Experimental Chronic Kidney Disease: A Placebo-Controlled Trial by Darren A. Yuen, David M. Kepecs, Yanling Zhang, Suzanne Advani, Kerri Thai, Kim A. Connelly, Richard E. Gilbert

Get full text

Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review by Neil E. Fleshner, Shabbir M. H. Alibhai, Kim A. Connelly, Ilidio Martins, Bernhard J. Eigl, Himu Lukka, Armen Aprikian

Get full text

Exercise‐Dependent Modulation of Immunological Response Pathways in Endurance Athletes With and Without Atrial Fibrillation by David Dorian, Dakota Gustafson, Ryan Quinn, Robert F. Bentley, Paul Dorian, Jack M. Goodman, Jason E. Fish, Kim A. Connelly

Get full text

The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis by Muhammad Usman Ali, G. B. John Mancini, Donna Fitzpatrick-Lewis, Kim A. Connelly, Eileen O’Meara, Shelley Zieroth, Diana Sherifali

Get full text

3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats. by Fay Lin Khong, Yuan Zhang, Amanda J Edgley, Weier Qi, Kim A Connelly, Owen L Woodman, Henry Krum, Darren J Kelly

Get full text

Baseline neutrophil‐to‐lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling by Raj Verma, Michael Moroney, Makoto Hibino, Cyril David Mazer, Kim A. Connelly, Andrew T. Yan, Adrian Quan, Hwee Teoh, Subodh Verma, Pankaj Puar

Get full text

Impact of diabetes duration on left ventricular mass regression with empagliflozin by Michael Moroney, Raj Verma, Makoto Hibino, C. David Mazer, Kim A. Connelly, Andrew T. Yan, Adrian Quan, Hwee Teoh, Subodh Verma, Pankaj Puar

Get full text

IGFBP7 and left ventricular mass regression: a sub‐analysis of the EMPA‐HEART CardioLink‐6 randomized clinical trial by Pankaj Puar, Nikhil Mistry, Kim A. Connelly, Andrew T. Yan, Adrian Quan, Hwee Teoh, Yi Pan, Raj Verma, David A. Hess, Subodh Verma, C. David Mazer

Get full text

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin by Pankaj Puar, Makoto Hibino, C. David Mazer, Andrew T. Yan, Arjun K. Pandey, Adrian Quan, Hwee Teoh, David A. Hess, Raj Verma, Kim A. Connelly, Subodh Verma

Get full text

Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy by Binita Riya Chacko, Gauri R. Karur, Kim A. Connelly, Raymond T. Yan, Anish Kirpalani, Rachel Wald, Laura Jimenez-Juan, John Roshan Jacob, Djeven P. Deva, Andrew T. Yan

Get full text

Evaluating the 12-Lead Electrocardiogram for Diagnosing ARVC in Young Populations: Implications for Preparticipation Screening of Athletes by Cameron H. Landry, MD, MSc, Meena Fatah, BSc, Kim A. Connelly, MBBS, PhD, Paul Angaran, MD, MSc, Robert M. Hamilton, MD, MHSc, Paul Dorian, MD, MSc

Get full text

Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction by Kim A. Connelly, Yanling Zhang, Jean-François Desjardins, Linda Nghiem, Aylin Visram, Sri N. Batchu, Verra G. Yerra, Golam Kabir, Kerri Thai, Andrew Advani, Richard E. Gilbert

Get full text

Experimental Right Ventricular Hypertension Induces Regional β1‐Integrin–Mediated Transduction of Hypertrophic and Profibrotic Right and Left Ventricular Signaling by Mei Sun, Ryo Ishii, Kenichi Okumura, Adrienn Krauszman, Siegfried Breitling, Olga Gomez, Aleksander Hinek, Stellar Boo, Boris Hinz, Kim A. Connelly, Wolfgang M. Kuebler, Mark K. Friedberg

Get full text

Lactate topography of the human brain using hyperpolarized 13C-MRI by Casey Y. Lee, Hany Soliman, Benjamin J. Geraghty, Albert P. Chen, Kim A. Connelly, Ruby Endre, William J. Perks, Chris Heyn, Sandra E. Black, Charles H. Cunningham

Get full text

Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial by William Barbour, Erika Wolff, Pankaj Puar, Makoto Hibino, Ehab Bakbak, Aishwarya Krishnaraj, Raj Verma, Meena Verma, Adrian Quan, Andrew T. Yan, Kim A. Connelly, Hwee Teoh, C. David Mazer, Subodh Verma

Get full text